{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:41:35Z","timestamp":1780472495316,"version":"3.54.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1998,9,1]],"date-time":"1998-09-01T00:00:00Z","timestamp":904608000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[1998,9]]},"DOI":"10.1007\/bf01450892","type":"journal-article","created":{"date-parts":[[2005,4,12]],"date-time":"2005-04-12T15:42:46Z","timestamp":1113320566000},"page":"359-363","source":"Crossref","is-referenced-by-count":26,"title":["Sulphasalazine in the treatment of children with chronic arthritis"],"prefix":"10.1007","volume":"17","author":[{"given":"Jing-Long","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1136\/bmj.280.6212.442","volume":"279","author":"B McConkey","year":"1980","unstructured":"McConkey B, Amos RS, Butcher RA, et al. Sulphasalazine in rheumatoid arthritis. Br Med J 1980;279:442?4.","journal-title":"Br Med J"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1136\/bmj.287.6399.1099","volume":"287","author":"VC Neumann","year":"1983","unstructured":"Neumann VC, Grundulis KA, Hubball S, et al. Comparison between penicillamine and sulphasalazine in rheumatoid arthritis. Br Med J 1983;287:1099?102.","journal-title":"Br Med J"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1136\/ard.44.3.194","volume":"44","author":"DE Bax","year":"1985","unstructured":"Bax DE, Amos RS. Sulphasalazine: a safe effective agent for prolonged control of rheumatoid arthritis: a comparison with sodium aurothiomalate. Ann Rheum Dis 1985;44:194?8.","journal-title":"Ann Rheum Dis"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/art.1780310905","volume":"31","author":"M Nissila","year":"1988","unstructured":"Nissila M, Lehtinen K, Leirisalo-Repo M, Luukhainen R, Mutru O, Yli-Kertula U. Sulphasalazine in the treatment of ankylosing spondylitis. Arthritis Rheum 1988;31:1111?6.","journal-title":"Arthritis Rheum"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/rheumatology\/32.8.729","volume":"32","author":"J Kirwan","year":"1993","unstructured":"Kirwan J, Edwards A, Huitfeldt B, Thompson P, Currey H. The course of establishing ankylosing spondylitis and the effects of sulphasalazine over 3 years. Br J Rheumatol 1993;32:729?33.","journal-title":"Br J Rheumatol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1136\/bmj.293.6552.911","volume":"293","author":"M Dougados","year":"1986","unstructured":"Dougados M, Boumier P, Amor B. Sulphasalazine in ankylosing spondylitis: a double blind controlled study in 60 patients. Br Med J 1986;293:911?4.","journal-title":"Br Med J"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1136\/bmj.287.6399.1102","volume":"287","author":"T Pullar","year":"1983","unstructured":"Pullar T, Hunter JA, Capell HA. Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate. Br Med J 1983;287:1102?4.","journal-title":"Br Med J"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1002\/art.1780291202","volume":"29","author":"RS Pinala","year":"1986","unstructured":"Pinala RS, Kaplan SB, Lawson JG, Hepburn B. Sulfasalazine in rheumatoid arthritis: a double-blind, placebo-controlled trial. Arthritis Rheum 1986;29:1427?34.","journal-title":"Arthritis Rheum"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/art.1780310602","volume":"31","author":"HJ Williams","year":"1988","unstructured":"Williams HJ, Ward JR, Dahl SL, et al. A controlled trial comparing sulfasalazine, gold sodium thiomalate, and placebo in rheumatoid arthritis. Arthritis Rheum 1988;31:702?13.","journal-title":"Arthritis Rheum"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1002\/art.1780331001","volume":"33","author":"DT Felson","year":"1990","unstructured":"Felson DT, Anderson JJ, Meenan RF. The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis: results of two metaanalysis. Arthritis Rheum 1990;33:1449?61.","journal-title":"Arthritis Rheum"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1136\/ard.48.5.389","volume":"48","author":"IH Nuver-Zwart","year":"1989","unstructured":"Nuver-Zwart IH, van Riel PLCM, van de Putte LBA, Gribnau FWJ. A double blind comparative study of sulphasalazine and hydroxychloroquine in rheumatoid arthritis: evidence of an earlier effect of sulphasalazine. Ann Rheum Dis 1989;48:389?95.","journal-title":"Ann Rheum Dis"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/rheumatology\/31.4.253","volume":"31","author":"MJH Wijnands","year":"1992","unstructured":"Wijnands MJH, van Hof MA, van Leeuwen MA, van Rijswijle MH, van de Putte LBA, van riel PLCM. Long-term second-line treatment: a prospective drug survival study. Br J Rheumatol 1992;31:253?8.","journal-title":"Br J Rheumatol"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1002\/art.1780361104","volume":"36","author":"P Hannonen","year":"1993","unstructured":"Hannonen P, Mottonen T, Hakola M, Oka M. Sulfasalazine in early rheumatoid arthritis: a 48-week double-blind, prospective, placebo-controlled study. Arthritis Rheum 1993;36:1501?9.","journal-title":"Arthritis Rheum"},{"key":"CR14","first-page":"124","volume":"13","author":"H Ozdogan","year":"1986","unstructured":"Ozdogan H, Turuns M, Deringol B, Yurdakul S, Yazici H. Sulphasalazine in the treatment of rheumatoid arthritis: a preliminary open trial. J Rheumatol 1986;13:124?5.","journal-title":"J Rheumatol"},{"issue":"suppl","key":"CR15","first-page":"122","volume":"36","author":"LF Imundo","year":"1993","unstructured":"Imundo LF, Jacobs JC. Treatment of juvenile arthritis (JA) with sulphasalazine. Arthritis Rheum 1993;36(suppl):s122.","journal-title":"Arthritis Rheum"},{"key":"CR16","first-page":"880","volume":"18","author":"R Joos","year":"1991","unstructured":"Joos R, Veys EM, Mielants H, van Werveke S, Goemaere S. Sulfasalazine treatment in juvenile chronic arthritis: an open study. J Rheumatol 1991;18:880?4.","journal-title":"J Rheumatol"},{"key":"CR17","first-page":"201","volume":"9","author":"BM Ansell","year":"1991","unstructured":"Ansell BM, Hall MA, Loftus JK, et al. A multicenter pilot study of sulphasalazine in juvenile chronic arthritis. Clin Exp Rheumatol 1991;9:201?3.","journal-title":"Clin Exp Rheumatol"},{"issue":"suppl","key":"CR18","first-page":"153","volume":"34","author":"C Job-Deslandre","year":"1991","unstructured":"Job-Deslandre C, Menkes CJ. Sulphasalazine in the treatment of juvenile spondyloarthropathy. Arthritis Rheum 1991;34 (suppl):s153","journal-title":"Arthritis Rheum"},{"key":"CR19","first-page":"658","volume":"140","author":"HJ Susche","year":"1992","unstructured":"Susche HJ. Treatment of juvenile spondyloarthritis and reactive arthritis with sulphasalazine. Monatsschr Kinderheilkd 1992;140:658?60.","journal-title":"Monatsschr Kinderheilkd"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0889-857X(05)70348-3","volume":"23","author":"R Burgos-Vargas","year":"1997","unstructured":"Burgos-Vargas R, Pacheco-Tena C, Vazguez-Mellado J. Juvenileonset spondyloarthropathy. Rheum Dis Clin North Am 1997;23:569?99.","journal-title":"Rheum Dis Clin North Am"},{"issue":"suppl","key":"CR21","first-page":"195","volume":"20","author":"EJ Brewer","year":"1977","unstructured":"Brewer EJ, Bass J, Baum J, et al. Current proposed revision of JRA criteria. Arthritis Rheum 1977;20(suppl):195?9.","journal-title":"Arthritis Rheum"},{"key":"CR22","first-page":"1041","volume":"25","author":"BH Bennett","year":"1967","unstructured":"Bennett BH, Birch TA. New York symposium on population studies in the rheumatic diseases: new diagnostic criteria. Bull Rheum Dis 1967;25:1041?7.","journal-title":"Bull Rheum Dis"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/art.1780250902","volume":"25","author":"AM Rosenberg","year":"1982","unstructured":"Rosenberg AM, Petty RE. A syndrome of seronegative enthesopathy and arthropathy in children. Arthritis Rheum 1982;25:1041?7.","journal-title":"Arthritis Rheum"},{"key":"CR24","first-page":"1282","volume":"19","author":"DA Cabral","year":"1992","unstructured":"Cabral DA, Oen Kg, Petty RE. SEA syndrome revisited: a longerm follow-up of children with a syndrome of seronegative enthesopathy and arthropathy. J Rheumatol 1992;19:1282?5.","journal-title":"J Rheumatol"},{"key":"CR25","first-page":"192","volume":"16","author":"R Burgos-Vargas","year":"1989","unstructured":"Burgos-Vargas R, Clark P. Axial involvement of the seronegative enthesopathy and arthropathy syndrome and its progression to ankylosing spondylitis. J Rheumatol 1989;16:192?7.","journal-title":"J Rheumatol"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/BF00441545","volume":"148","author":"A Hussein","year":"1989","unstructured":"Hussein A, Abdul-Khaliq H, von der Hardt H. Atypical spondyloarthritis in children: proposed diagnostic criteria. Eur J Pediatr 1989;148:513?7.","journal-title":"Eur J Pediatr"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0022-3476(82)80746-4","volume":"100","author":"JC Jacobs","year":"1982","unstructured":"Jacobs JC, Berdon WE, Johnston AD. HLA-B27-associated spondyloarthritis and enthesopathy in childhood: clinical, pathologic, and radiographic observations in 58 patients. J Pediatr 1982;100:521?8.","journal-title":"J Pediatr"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1136\/gut.24.3.213","volume":"24","author":"CJ Hawkey","year":"1983","unstructured":"Hawkey CJ, Truelove SC. Inhibition of prostaglandin synthetase in human rectal mucosa. Gut 1983;24:213?7.","journal-title":"Gut"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1136\/gut.22.8.642","volume":"22","author":"JM Rhodes","year":"1981","unstructured":"Rhodes JM, Bartholomew TC, Jewell DP. Inhibition of leukocyte motility by drugs used in ulcerative colitis. Gut 1981;22:642?7.","journal-title":"Gut"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1136\/ard.40.3.293","volume":"40","author":"SD Carter","year":"1981","unstructured":"Carter SD, Bacon PA, Hall ND. Characterization of activated lymphocytes in the peripheral blood of patients with rheumatoid arthritis. Ann Rheum Dis 1981;40:293?8.","journal-title":"Ann Rheum Dis"},{"key":"CR31","first-page":"199","volume":"18","author":"R Madhok","year":"1991","unstructured":"Madhok R, Wijelath E, Smith J, Watson J, Sturrock RD, Capell HA. Is the beneficial effect of sulphasalazine due to inhibition of synovial neovascularization? J Rheumatol 1991;18:199?202.","journal-title":"J Rheumatol"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1136\/gut.34.2.252","volume":"34","author":"SM Greenfield","year":"1993","unstructured":"Greenfield SM, Hamblin AS, Shakoor ZS, Teare JP, Punchard NA, Thompson RPH. Inhibition of leukocyte adhesion molecule upregulation by tumor necrosis factor: a novel mechanism of action of sulphasalazine. Gut 1993;34:256?6.","journal-title":"Gut"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01450892.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01450892\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01450892","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T14:18:22Z","timestamp":1556806702000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01450892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,9]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1998,9]]}},"alternative-id":["BF01450892"],"URL":"https:\/\/doi.org\/10.1007\/bf01450892","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,9]]}}}